Table of Content

1 Study Coverage
1.1 Plasma-derived Medicinal Products Product Introduction
1.2 Market by Type
1.2.1 Global Plasma-derived Medicinal Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market by Application
1.3.1 Global Plasma-derived Medicinal Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Emergency Care
1.3.3 Epidemic Diseasae
1.3.4 Immune System Disorder
1.3.5 Antibody Deficiency
1.3.6 Coagulation Disorder
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts 2018-2029
2.2 Global Plasma-derived Medicinal Products Revenue by Region
2.2.1 Global Plasma-derived Medicinal Products Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Plasma-derived Medicinal Products Revenue by Region (2018-2024)
2.2.3 Global Plasma-derived Medicinal Products Revenue by Region (2024-2029)
2.2.4 Global Plasma-derived Medicinal Products Revenue Market Share by Region (2018-2029)
2.3 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts 2018-2029
2.4 Global Plasma-derived Medicinal Products Sales by Region
2.4.1 Global Plasma-derived Medicinal Products Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Plasma-derived Medicinal Products Sales by Region (2018-2024)
2.4.3 Global Plasma-derived Medicinal Products Sales by Region (2024-2029)
2.4.4 Global Plasma-derived Medicinal Products Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Plasma-derived Medicinal Products Sales by Manufacturers
3.1.1 Global Plasma-derived Medicinal Products Sales by Manufacturers (2018-2024)
3.1.2 Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma-derived Medicinal Products in 2022
3.2 Global Plasma-derived Medicinal Products Revenue by Manufacturers
3.2.1 Global Plasma-derived Medicinal Products Revenue by Manufacturers (2018-2024)
3.2.2 Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plasma-derived Medicinal Products Revenue in 2022
3.3 Global Key Players of Plasma-derived Medicinal Products, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Plasma-derived Medicinal Products Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plasma-derived Medicinal Products, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plasma-derived Medicinal Products, Product Offered and Application
3.8 Global Key Manufacturers of Plasma-derived Medicinal Products, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma-derived Medicinal Products Sales by Type
4.1.1 Global Plasma-derived Medicinal Products Historical Sales by Type (2018-2024)
4.1.2 Global Plasma-derived Medicinal Products Forecasted Sales by Type (2024-2029)
4.1.3 Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
4.2 Global Plasma-derived Medicinal Products Revenue by Type
4.2.1 Global Plasma-derived Medicinal Products Historical Revenue by Type (2018-2024)
4.2.2 Global Plasma-derived Medicinal Products Forecasted Revenue by Type (2024-2029)
4.2.3 Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
4.3 Global Plasma-derived Medicinal Products Price by Type
4.3.1 Global Plasma-derived Medicinal Products Price by Type (2018-2024)
4.3.2 Global Plasma-derived Medicinal Products Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Plasma-derived Medicinal Products Sales by Application
5.1.1 Global Plasma-derived Medicinal Products Historical Sales by Application (2018-2024)
5.1.2 Global Plasma-derived Medicinal Products Forecasted Sales by Application (2024-2029)
5.1.3 Global Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
5.2 Global Plasma-derived Medicinal Products Revenue by Application
5.2.1 Global Plasma-derived Medicinal Products Historical Revenue by Application (2018-2024)
5.2.2 Global Plasma-derived Medicinal Products Forecasted Revenue by Application (2024-2029)
5.2.3 Global Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
5.3 Global Plasma-derived Medicinal Products Price by Application
5.3.1 Global Plasma-derived Medicinal Products Price by Application (2018-2024)
5.3.2 Global Plasma-derived Medicinal Products Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Plasma-derived Medicinal Products Market Size by Type
6.1.1 US & Canada Plasma-derived Medicinal Products Sales by Type (2018-2029)
6.1.2 US & Canada Plasma-derived Medicinal Products Revenue by Type (2018-2029)
6.2 US & Canada Plasma-derived Medicinal Products Market Size by Application
6.2.1 US & Canada Plasma-derived Medicinal Products Sales by Application (2018-2029)
6.2.2 US & Canada Plasma-derived Medicinal Products Revenue by Application (2018-2029)
6.3 US & Canada Plasma-derived Medicinal Products Market Size by Country
6.3.1 US & Canada Plasma-derived Medicinal Products Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Plasma-derived Medicinal Products Sales by Country (2018-2029)
6.3.3 US & Canada Plasma-derived Medicinal Products Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plasma-derived Medicinal Products Market Size by Type
7.1.1 Europe Plasma-derived Medicinal Products Sales by Type (2018-2029)
7.1.2 Europe Plasma-derived Medicinal Products Revenue by Type (2018-2029)
7.2 Europe Plasma-derived Medicinal Products Market Size by Application
7.2.1 Europe Plasma-derived Medicinal Products Sales by Application (2018-2029)
7.2.2 Europe Plasma-derived Medicinal Products Revenue by Application (2018-2029)
7.3 Europe Plasma-derived Medicinal Products Market Size by Country
7.3.1 Europe Plasma-derived Medicinal Products Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Plasma-derived Medicinal Products Sales by Country (2018-2029)
7.3.3 Europe Plasma-derived Medicinal Products Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plasma-derived Medicinal Products Market Size
8.1.1 China Plasma-derived Medicinal Products Sales (2018-2029)
8.1.2 China Plasma-derived Medicinal Products Revenue (2018-2029)
8.2 China Plasma-derived Medicinal Products Market Size by Application
8.2.1 China Plasma-derived Medicinal Products Sales by Application (2018-2029)
8.2.2 China Plasma-derived Medicinal Products Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Plasma-derived Medicinal Products Market Size by Type
9.1.1 Asia Plasma-derived Medicinal Products Sales by Type (2018-2029)
9.1.2 Asia Plasma-derived Medicinal Products Revenue by Type (2018-2029)
9.2 Asia Plasma-derived Medicinal Products Market Size by Application
9.2.1 Asia Plasma-derived Medicinal Products Sales by Application (2018-2029)
9.2.2 Asia Plasma-derived Medicinal Products Revenue by Application (2018-2029)
9.3 Asia Plasma-derived Medicinal Products Sales by Region
9.3.1 Asia Plasma-derived Medicinal Products Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Plasma-derived Medicinal Products Revenue by Region (2018-2029)
9.3.3 Asia Plasma-derived Medicinal Products Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plasma-derived Medicinal Products Market Size by Type
10.1.1 Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Plasma-derived Medicinal Products Market Size by Application
10.2.1 Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Country
10.3.1 Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Octapharma Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Kedrion Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 LFB Group Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Biotest Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Overview
11.8.3 BPL Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 BPL Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shanghai RAAS Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 China Biologic Products
11.10.1 China Biologic Products Company Information
11.10.2 China Biologic Products Overview
11.10.3 China Biologic Products Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 China Biologic Products Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 China Biologic Products Recent Developments
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Information
11.11.2 Hualan Biological Engineering Inc. Overview
11.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Biological Engineering Inc. Recent Developments
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Information
11.12.2 Beijing Tiantan Biological Products Corp Overview
11.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Beijing Tiantan Biological Products Corp Recent Developments
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Information
11.13.2 Pacific Shuanglin Overview
11.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Pacific Shuanglin Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pacific Shuanglin Recent Developments
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Information
11.14.2 Boya Bio-Pharmaceutical Overview
11.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Boya Bio-Pharmaceutical Recent Developments
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Overview
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Information
11.16.2 Xinjiang Deyuan Bioengineering Overview
11.16.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Xinjiang Deyuan Bioengineering Recent Developments
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Overview
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Information
11.18.2 Shenzhen Weiguang Overview
11.18.3 Shenzhen Weiguang Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Shenzhen Weiguang Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Shenzhen Weiguang Recent Developments
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Information
11.19.2 Shanxi Kangbao Overview
11.19.3 Shanxi Kangbao Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Shanxi Kangbao Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Shanxi Kangbao Recent Developments
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Information
11.20.2 Nanyue Biopharming Corporation Ltd Overview
11.20.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma-derived Medicinal Products Industry Chain Analysis
12.2 Plasma-derived Medicinal Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma-derived Medicinal Products Production Mode & Process
12.4 Plasma-derived Medicinal Products Sales and Marketing
12.4.1 Plasma-derived Medicinal Products Sales Channels
12.4.2 Plasma-derived Medicinal Products Distributors
12.5 Plasma-derived Medicinal Products Customers
13 Market Dynamics
13.1 Plasma-derived Medicinal Products Industry Trends
13.2 Plasma-derived Medicinal Products Market Drivers
13.3 Plasma-derived Medicinal Products Market Challenges
13.4 Plasma-derived Medicinal Products Market Restraints
14 Key Findings in The Global Plasma-derived Medicinal Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma-derived Medicinal Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Immunoglobulins
Table 3. Major Manufacturers of Coagulation Factor Concentrates
Table 4. Major Manufacturers of Other
Table 5. Global Plasma-derived Medicinal Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Plasma-derived Medicinal Products Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Plasma-derived Medicinal Products Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Plasma-derived Medicinal Products Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2018-2024)
Table 10. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2024-2029)
Table 11. Global Plasma-derived Medicinal Products Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Plasma-derived Medicinal Products Sales by Region (2018-2024) & (K Units)
Table 13. Global Plasma-derived Medicinal Products Sales by Region (2024-2029) & (K Units)
Table 14. Global Plasma-derived Medicinal Products Sales Market Share by Region (2018-2024)
Table 15. Global Plasma-derived Medicinal Products Sales Market Share by Region (2024-2029)
Table 16. Global Plasma-derived Medicinal Products Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Plasma-derived Medicinal Products Sales Share by Manufacturers (2018-2024)
Table 18. Global Plasma-derived Medicinal Products Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Plasma-derived Medicinal Products, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Plasma-derived Medicinal Products Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Plasma-derived Medicinal Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Plasma-derived Medicinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2022)
Table 24. Global Key Manufacturers of Plasma-derived Medicinal Products, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Plasma-derived Medicinal Products, Product Offered and Application
Table 26. Global Key Manufacturers of Plasma-derived Medicinal Products, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 29. Global Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 30. Global Plasma-derived Medicinal Products Sales Share by Type (2018-2024)
Table 31. Global Plasma-derived Medicinal Products Sales Share by Type (2024-2029)
Table 32. Global Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Plasma-derived Medicinal Products Revenue Share by Type (2018-2024)
Table 35. Global Plasma-derived Medicinal Products Revenue Share by Type (2024-2029)
Table 36. Plasma-derived Medicinal Products Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Plasma-derived Medicinal Products Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 39. Global Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 40. Global Plasma-derived Medicinal Products Sales Share by Application (2018-2024)
Table 41. Global Plasma-derived Medicinal Products Sales Share by Application (2024-2029)
Table 42. Global Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Plasma-derived Medicinal Products Revenue Share by Application (2018-2024)
Table 45. Global Plasma-derived Medicinal Products Revenue Share by Application (2024-2029)
Table 46. Plasma-derived Medicinal Products Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Plasma-derived Medicinal Products Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Plasma-derived Medicinal Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Plasma-derived Medicinal Products Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Plasma-derived Medicinal Products Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Plasma-derived Medicinal Products Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Plasma-derived Medicinal Products Sales by Country (2024-2029) & (K Units)
Table 61. Europe Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 62. Europe Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 63. Europe Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 66. Europe Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 67. Europe Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Plasma-derived Medicinal Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Plasma-derived Medicinal Products Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Plasma-derived Medicinal Products Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Plasma-derived Medicinal Products Sales by Country (2018-2024) & (K Units)
Table 73. Europe Plasma-derived Medicinal Products Sales by Country (2024-2029) & (K Units)
Table 74. China Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 75. China Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 76. China Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 79. China Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 80. China Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 83. Asia Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 84. Asia Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 87. Asia Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 88. Asia Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Plasma-derived Medicinal Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Plasma-derived Medicinal Products Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Plasma-derived Medicinal Products Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Plasma-derived Medicinal Products Sales by Region (2018-2024) & (K Units)
Table 94. Asia Plasma-derived Medicinal Products Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales by Country (2024-2029) & (K Units)
Table 108. Takeda Company Information
Table 109. Takeda Description and Major Businesses
Table 110. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Takeda Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Takeda Recent Developments
Table 113. CSL Company Information
Table 114. CSL Description and Major Businesses
Table 115. CSL Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. CSL Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. CSL Recent Developments
Table 118. Grifols Company Information
Table 119. Grifols Description and Major Businesses
Table 120. Grifols Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Grifols Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Grifols Recent Developments
Table 123. Octapharma Company Information
Table 124. Octapharma Description and Major Businesses
Table 125. Octapharma Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Octapharma Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Octapharma Recent Developments
Table 128. Kedrion Company Information
Table 129. Kedrion Description and Major Businesses
Table 130. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Kedrion Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Kedrion Recent Developments
Table 133. LFB Group Company Information
Table 134. LFB Group Description and Major Businesses
Table 135. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. LFB Group Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. LFB Group Recent Developments
Table 138. Biotest Company Information
Table 139. Biotest Description and Major Businesses
Table 140. Biotest Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Biotest Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Biotest Recent Developments
Table 143. BPL Company Information
Table 144. BPL Description and Major Businesses
Table 145. BPL Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. BPL Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. BPL Recent Developments
Table 148. Shanghai RAAS Company Information
Table 149. Shanghai RAAS Description and Major Businesses
Table 150. Shanghai RAAS Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Shanghai RAAS Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Shanghai RAAS Recent Developments
Table 153. China Biologic Products Company Information
Table 154. China Biologic Products Description and Major Businesses
Table 155. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. China Biologic Products Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. China Biologic Products Recent Developments
Table 158. Hualan Biological Engineering Inc. Company Information
Table 159. Hualan Biological Engineering Inc. Description and Major Businesses
Table 160. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Hualan Biological Engineering Inc. Recent Developments
Table 163. Beijing Tiantan Biological Products Corp Company Information
Table 164. Beijing Tiantan Biological Products Corp Description and Major Businesses
Table 165. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Beijing Tiantan Biological Products Corp Recent Developments
Table 168. Pacific Shuanglin Company Information
Table 169. Pacific Shuanglin Description and Major Businesses
Table 170. Pacific Shuanglin Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Pacific Shuanglin Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Pacific Shuanglin Recent Developments
Table 173. Boya Bio-Pharmaceutical Company Information
Table 174. Boya Bio-Pharmaceutical Description and Major Businesses
Table 175. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Boya Bio-Pharmaceutical Recent Developments
Table 178. Paisi Feike Biology Pharmacy Co., Ltd. Company Information
Table 179. Paisi Feike Biology Pharmacy Co., Ltd. Description and Major Businesses
Table 180. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
Table 183. Xinjiang Deyuan Bioengineering Company Information
Table 184. Xinjiang Deyuan Bioengineering Description and Major Businesses
Table 185. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Xinjiang Deyuan Bioengineering Recent Developments
Table 188. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
Table 189. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 190. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
Table 193. Shenzhen Weiguang Company Information
Table 194. Shenzhen Weiguang Description and Major Businesses
Table 195. Shenzhen Weiguang Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. Shenzhen Weiguang Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Shenzhen Weiguang Recent Developments
Table 198. Shanxi Kangbao Company Information
Table 199. Shanxi Kangbao Description and Major Businesses
Table 200. Shanxi Kangbao Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Shanxi Kangbao Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Shanxi Kangbao Recent Developments
Table 203. Nanyue Biopharming Corporation Ltd Company Information
Table 204. Nanyue Biopharming Corporation Ltd Description and Major Businesses
Table 205. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 206. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Nanyue Biopharming Corporation Ltd Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Plasma-derived Medicinal Products Distributors List
Table 211. Plasma-derived Medicinal Products Customers List
Table 212. Plasma-derived Medicinal Products Market Trends
Table 213. Plasma-derived Medicinal Products Market Drivers
Table 214. Plasma-derived Medicinal Products Market Challenges
Table 215. Plasma-derived Medicinal Products Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma-derived Medicinal Products Product Picture
Figure 2. Global Plasma-derived Medicinal Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Plasma-derived Medicinal Products Market Share by Type in 2022 & 2029
Figure 4. Immunoglobulins Product Picture
Figure 5. Coagulation Factor Concentrates Product Picture
Figure 6. Other Product Picture
Figure 7. Global Plasma-derived Medicinal Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Plasma-derived Medicinal Products Market Share by Application in 2022 & 2029
Figure 9. Emergency Care
Figure 10. Epidemic Diseasae
Figure 11. Immune System Disorder
Figure 12. Antibody Deficiency
Figure 13. Coagulation Disorder
Figure 14. Others
Figure 15. Plasma-derived Medicinal Products Report Years Considered
Figure 16. Global Plasma-derived Medicinal Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Plasma-derived Medicinal Products Revenue 2018-2029 (US$ Million)
Figure 18. Global Plasma-derived Medicinal Products Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2018-2029)
Figure 20. Global Plasma-derived Medicinal Products Sales 2018-2029 ((K Units)
Figure 21. Global Plasma-derived Medicinal Products Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Plasma-derived Medicinal Products Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Plasma-derived Medicinal Products Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Plasma-derived Medicinal Products Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Plasma-derived Medicinal Products Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Plasma-derived Medicinal Products Sales YoY (2018-2029) & (K Units)
Figure 27. China Plasma-derived Medicinal Products Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Plasma-derived Medicinal Products Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Plasma-derived Medicinal Products Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Plasma-derived Medicinal Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Plasma-derived Medicinal Products in the World: Market Share by Plasma-derived Medicinal Products Revenue in 2022
Figure 34. Global Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 36. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 37. Global Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 38. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Plasma-derived Medicinal Products Revenue Share by Country (2018-2029)
Figure 44. US & Canada Plasma-derived Medicinal Products Sales Share by Country (2018-2029)
Figure 45. U.S. Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 48. Europe Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 49. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 50. Europe Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 51. Europe Plasma-derived Medicinal Products Revenue Share by Country (2018-2029)
Figure 52. Europe Plasma-derived Medicinal Products Sales Share by Country (2018-2029)
Figure 53. Germany Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 54. France Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 58. China Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 59. China Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 60. China Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 61. China Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 62. Asia Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 63. Asia Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 64. Asia Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 65. Asia Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 66. Asia Plasma-derived Medicinal Products Revenue Share by Region (2018-2029)
Figure 67. Asia Plasma-derived Medicinal Products Sales Share by Region (2018-2029)
Figure 68. Japan Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 72. India Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Plasma-derived Medicinal Products Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Plasma-derived Medicinal Products Sales Share by Country (2018-2029)
Figure 79. Brazil Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Plasma-derived Medicinal Products Revenue (2018-2029) & (US$ Million)
Figure 84. Plasma-derived Medicinal Products Value Chain
Figure 85. Plasma-derived Medicinal Products Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed